September 3, 2014
The process of hiring qualified medical executives for your India office can be difficult. Due to Indias fast growth recently, there is increased competition to find the top medical talent to staff medical companies in India. There is a very strong demand for executives who have experience with product registration and compliance in the medical business. Quality assurance executives are also in short supply as medical manufacturers try and improve the quality of their factories and products to increase international sales.
July 24, 2014
India -- which has a population of 1.2 billion -- is the third largest medical device market in Asia. The total market for diagnostic and medical equipment in India is worth about $3.5 billion and is expanding at an annual rate of 18%.
However, India is forecast to suffer substantial human and economic costs from increasing rates of cancer. More than 1 million cancer cases are diagnosed annually in India -- and this number may reach 5 million over the next decade. Western medical companies that want to take advantage of the many opportunities in the Indian cancer sector should focus on clearly developing a strategy for the Indian market.
May 14, 2014
In Asia, rising patient awareness of homecare and an expanding middle class mean that demand for home healthcare is exploding. The Asian market for home healthcare products and services has a double digit annual growth rate. The Asian healthcare device market segment alone (not including home health services or other products) is expanding especially quickly and will reach $15 billion in 2017, up from $2 billion in 2012.
July 10, 2013
Nearly ten percent of India's 1.24 billion people suffer from chronic kidney disease (CKD), a disease in which the kidney slowly loses function and fails. One 2013 survey found that more than 15 percent of urban Indians have the disease, with rates almost 50 percent in some cities. As the number of CKD patients goes up, so has the size of the Indian dialysis market. It increased in value to more than $150 million in 2012, from $100 million in 2007. India's demand for dialysis is growing at a rate of 31 percent, compared to 6 percent in the US and 8 percent in the rest of the world.
February 5, 2013
The medical device market in India grew to $3 billion by the end of 2011. According to a recent report, that figure should more than triple over the next ten years, to reach $10 billion by 2022. While India's market grows at this fast pace, its regulators are looking to overhaul how medical devices are registered and marketed in their country. While some new regulations passed in 2012, a more comprehensive bill may again be before the Indian Parliament in 2013.
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to early 2012.
This medical device directory has been compiled and verified by Pacific Bridge Medical. This directory provides contact information and company profiles for 242 credible India based medical device manufacturers, distributors and exporters. This directory is indexed alphabetically by company name and by product category.
Pacific Bridge Medical presents India Medical Device Regulatory Updates, a 2012 webcast/webinar with an overview of medical device regulatory issues and the market in India.
Pacific Bridge Medical presents Strategies for Success in China, Japan, and India, a 2011 webcast/webinar with information on the key business and regulatory issues for drug and medical device markets in China, Japan, and India.
October 1, 2011
With a population of 1.2 billion, a growing middle class and a booming economy, India is experiencing increasing demand for medical devices. The Indian medical device market is thriving and currently has a total worth of about $3 billion (US), with growth anticipated at 12% to 16% over the next five years India is an important destination for foreign medical devices: imported products represent more than 70% of the market. As a huge growth opportunity, regulatory professionals need to closely follow the evolving Indian medical device regulations.
Pacific Bridge Medical presents 2011 India Medical Device Updates, a 2011 webcast/webinar with an overview of medical device regulatory issues and the market in India.
May 1, 2010
A group of Indian medical device manufacturers are lobbying for the following: changes in the current duty structure on medical devices, currency stability, cheaper credit for exporters, and greater representation of their interests in a medical export council. In February 2010, the All India Medical Devices Industry (AIMED) wrote a letter to the commerce and industry minister of India proposing that either Pharmexcil (an organization representing pharmaceutical exporters) broaden its scope to include the interests of the medical device industry, or a new Medical Export Promotion Council be established.
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2009.
September 1, 2009
In today's global recession, innovation, creativity and resourcefulness are essential. Using these tools to determine the appropriate regulatory strategy for your medical device could decide the success or failure of your product in Asia. This article provides the most recent regulatory updates in Japan, China and India to help gain entry to those markets.
Pacific Bridge Medical presents New Updates on India's Expanding Medical Device Market, a 2009 webcast/webinar with an overview of medical device regulatory issues and the market in India.
Pacific Bridge Medical presents Doing Business in India, a 2008 webcast/webinar providing strategies and tips for doing business in India.
November 1, 2008
It may sound intimidating, but if foreign companies are willing to do the legwork, there are many good reasons to consider launching a medical device plant in India. Few statistics on the country's device market are available but, with the help of our medical partner who has been in India for more than 10 years, we estimate the market to be about $2 billion, growing at 15% per year. The market's growth has been driven by an increase in both government and private sector expenditures in healthcare, increased coverage of medical insurance, and rising incomes.
Pacific Bridge Medical presents Managing Asian Cultural/Business Diversity, a 2008 webcast/webinar on cross-cultural issues for Western companies doing business in Asia.
November 1, 2007
This report helps medical device manufacturers and distributors better understand how to source from Asia. Topics covered include: how to identify manufacturers, how to perform due diligence, what to look for during factory visits, contract negotiations, regulatory requirements, logistics, quality control, and other issues related to the sourcing equation. This report will also offer advice on how to avoid and troubleshoot problems and pitfalls that may arise in the course of the sourcing process, as well as information about insurance, payment arrangements, freight forwarding, and customs.
Furthermore, we will include Microsoft Excel spreadsheet templates on CD-ROM with this report that will facilitate your transportation and shipping decisions when dealing with multiple SKUs being shipped in one container.
October 1, 2007
After decades of slow growth, India's economy is now advancing rapidly. From 1996 to 2006 its GDP grew at an average rate of 7% yearly, and this growth figure increased to 10% in 2006. It is expected to keep growing at 7% or higher over the next five years. With the fourth-largest economy in the world (as measured by purchasing power parity), India is finally coming into its own as a major world economy.
Total medical spending in India is growing quickly, driven by better-off Indians willing to pay privately for modern care from private hospitals. This increased spending creates many opportunities for foreign pharmaceutical companies. India's $9 billion pharmaceutical market saw 10% growth in 2006, and double-digit growth is predicted to continue through 2012. In addition, the country's low labor costs, large existing pharmaceutical manufacturing base, and sizable patient population make it an excellent location for Western companies to do contract manufacturing, clinical research, and R&D.
April 1, 2007
For a long time, India was closed to many foreign markets through government protectionism and a nationalistic tariff system. Today, however, India is ripe for market entry for many industries, including medical devices. Entering soon (or expanding one’s business there) will help keep Western enterprises from being left out of India's exponential growth.
Pacific Bridge Medical presents Update on India's Medical Device Markets, a 2007 webcast/webinar providing an overview of regulatory and market issues for medical devices in India.
Pacific Bridge Medical presents India's Pharmaceutical Markets, a 2006 webcast/webinar providing an overview of India's product registration and regulatory requirements for pharmaceutical/drug manufacturers.
PBM presents India's Medical Markets, a webcast/webinar that includes information on medical device and drug/pharmaceutical regulations and issues in India.
October 1, 2005
Pharmaceutical and medical device markets are expanding throughout Asia. This presentation covers the medical device and pharmaceutical markets in Taiwan, Hong Kong, Malaysia, Singapore, India and Vietnam, and provides country-specific information about drug, device and IVD regulations in these countries. Specific topics include registration, pricing and reimbursement, manufacturing and GMP, import licenses, patents, and clinical trials in these countries.
June 1, 2005
This presentation provides information on the medical device regulatory environments for Japan, China, Taiwan, Hong Kong, Korea, Malaysia, Singapore, the Philippines, and India. Some of the specific topics covered include Japans new Pharmaceutical Affairs Law (PAL) and Marketing Authorization Holder (MAH) System; the medical device registration process in China; and the reimbursement process in Taiwan.
May 1, 2002
After India's entry into the World Trade Organization (WTO), consumer goods imports and free imports greatly increased, allowing the market to slowly open up to foreign investment and medical products. This article covers the major features of the market, law and policy associated with the pharmaceuticals industry in India. There are several departments and regulations in India which help control pharmaceutical regulation; including the Drugs and Cosmetics Act (DCA), the Department of Chemicals and Fertilizers, Ministry of Chemicals and Petrochemicals, the Drug Controller of India (DCI), and the Drug Prices Control Order Act (DPCO). These regulatory bodies and acts help maintain pharmaceutical regulatory procedures like product approval, manufacturing, importing and licensing, tariffs, pricing, marketing and distribution, patents and trademarks, and market entry and investment.
August 1, 2001
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard of living throughout the region means patients will have the resources to acquire modern medical devices and pharmaceuticals. As the globalization of healthcare continues, regulatory practices for pharmaceuticals and medical devices will be further harmonized. This report examines emerging regulatory trends and issues in China, Japan, Hong Kong, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand.
July 1, 1999
Recovering economies throughout Asia offer promising markets for foreign medical device firms as well as opportunities for local product development and manufacturing. Before the Asian financial crisis, regional medical device markets grew at double-digit rates. Patients wanted the technologically innovative, cost-effective devices that foreign medical manufactures could provide. Many Asian countries became dependent on imports. Those factors strong demand and lack of domestic competition remained after the crisis. Furthermore, currency depreciation made it cheaper to establish local facilities for manufacturing and product development. This article features examinations of Japan, China, Singapore, Taiwan, India, Thailand and Malaysia.
February 1, 1999
This article discusses some of the major issues facing foreign pharmaceutical companies looking to invest in the Indian market. India's pharmaceutical sector continues to grow at an annual rate of 15%-20%, and currently its pharmaceutical market is ninth in the world. Despite the widespread use of ayurvedic medicine and homeopathy, the demand for imports from foreign drug companies continues to increase. The Drugs Controller of India (DCI) and State Food and Drug Administrations (FDAs) are responsible for drug regulation and control, while the Drug Price Control Orders (DPCO) have been implemented to assist with price control. Additionally, the Trade-Related Intellectual Property Rights (TRIPs) has been put into effect by the Indian government to protect foreign drug products. Understanding these regulatory procedures, price control and patent protection issues is key to foreign companies hoping to ensure their long-term place in the industry.
July 1, 1998
Despite its currency crisis, Asia still offers manufacturers many opportunities.
Asia's recent currency crisis has caused some U.S. medical device companies to wonder whether there is still a market for their products and services. Concern has risen that Asians have lost their purchasing power, meaning a decrease in U.S. exports to Asia and an unstable economic environment in which to invest. However, not all manufacturers have fled the region. Several companies feel that the crisis has opened new opportunities for manufacturing in Southeast Asia.
November 1, 1995
Despite a burgeoning population exceeding 1 billion, India's government is aiming to protect its citizens by providing quality medical care to all Indians, including those living in rural areas. This national priority will require increased numbers of imported medical device equipment, which already constitutes about half of the Indian medical market. With information regarding India's healthcare structure, medical device market and market entry strategies, this article draws attention to the changes that are being made by the government, the promise of growth in the medical device market, and the particularities of entering the market in India. There are many ways in which medical device suppliers can receive assistance with their entry into the market, including finding a domestic partner or hiring a domestic distributor or agent to help market and sell the product in India.
September 1, 1994
This article provides information on the growing possibilities of the Indian medical market in the coming years. India’s increasing affluent middle class, the public versus private hospital question, growing rates of cancer and other deadly diseases, and local agreements between foreign device manufacturers and Indian manufacturers are some of the main factors that are affecting the growth of the Indian medical market. As the wealthier middle class grows, demands for better medical treatment with higher technology products will be met at private hospitals, rather than the government-run public hospitals. Market entry can be facilitated by working with local companies – General Electric (GE) has maintained one of the most successful positions in the medical market by partnering with the Indian manufacturer Wipro.
Back to Top